alpha-Adrenergic receptor regulation of skeletal muscle blood flow during exercise in heart failure patients with reduced ejection fraction

摘要

Patients suffering from heart failure with reduced ejection fraction (HFrEF) experience impaired limb blood flow during exercise, which may be due to a disease-related increase in a-adrenergic receptor vasoconstriction. Thus, in eight patients with HFrEF (63 ?4 yr) and eight well-matched controls (63 ?2 yr), we examined changes in leg blood How (Doppler ultrasound) during intra-arterial infusion of phenylephrine (PE; an oti-adrenergic receptor agonist) and phentolamine (Phen; a nonspecific a-adrenergic receptor antagonist) at rest and during dynamic single-leg knee-extensor exercise (0, 5, and 10 W). At rest, the PE-induced reduction in blood flow was significantly attenuated in patients with HFrEF (-15 ?7) compared with controls (-36 ?5). During exercise, the controls exhibited a blunted reduction in blood flow induced by PE (- 12 ?4, - 10 ?4, and -9 ?2 at 0, 5, and 10 W, respectively) compared with rest, while the PE-induced change in blood flow was unchanged compared with rest in the HFrEF group (-8 ?5, -10 ?3, and -14 ?3, respectively). Phen administration increased leg blood flow to a greater extent in the HFrEF group at rest (+178 ?4 vs. +114 ?8, HFrEF vs. control) and during exercise (36 ?6, 37 ?7, and 39 ?6 vs. 13 ?3, 14 ?1, and 8 ?3 at 0, 5, and 10 W, respectively, in HFrEF vs. control). Together, these findings imply that a HFrEF-related increase in a-adrenergic vasoconstriction restrains exercising skeletal muscle blood flow, potentially contributing to diminished exercise capacity in this population.